Organization: Health Canada
Year: 2022
Month: July
Request Number: A-2022-000063
Request Summary: Adverse Drug Reactions (ADRs) for Mesalazine. Report numbers: 000978470, 000981367. ADR for Mesalamine. Report number: E2B_05076794. ADRs for C1 Esterase Inhibitor (Human). Report numbers: E2B_05005315, E2B_05050243, E2B_04959588. ADR for GAMMAGARD LIQUID. Report number: 979947. ADRs for Immunoglobulin (human). Report numbers: E2B_04999330, E2B_05080402, E2B_05008731.
Disposition: Disclosed in part
Number of pages: 79